These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 31449679)
1. Protocadherin 7 is overexpressed in castration resistant prostate cancer and promotes aberrant MEK and AKT signaling. Shishodia G; Koul S; Koul HK Prostate; 2019 Nov; 79(15):1739-1751. PubMed ID: 31449679 [TBL] [Abstract][Full Text] [Related]
2. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway. Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216 [TBL] [Abstract][Full Text] [Related]
3. PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis. Zhou X; Updegraff BL; Guo Y; Peyton M; Girard L; Larsen JE; Xie XJ; Zhou Y; Hwang TH; Xie Y; Rodriguez-Canales J; Villalobos P; Behrens C; Wistuba II; Minna JD; O'Donnell KA Cancer Res; 2017 Jan; 77(1):187-197. PubMed ID: 27821484 [TBL] [Abstract][Full Text] [Related]
4. MET inhibition enhances PARP inhibitor efficacy in castration-resistant prostate cancer by suppressing the ATM/ATR and PI3K/AKT pathways. Zhou S; Dai Z; Wang L; Gao X; Yang L; Wang Z; Wang Q; Liu Z J Cell Mol Med; 2021 Dec; 25(24):11157-11169. PubMed ID: 34761497 [TBL] [Abstract][Full Text] [Related]
5. CCR1/CCL5 interaction promotes invasion of taxane-resistant PC3 prostate cancer cells by increasing secretion of MMPs 2/9 and by activating ERK and Rac signaling. Kato T; Fujita Y; Nakane K; Mizutani K; Terazawa R; Ehara H; Kanimoto Y; Kojima T; Nozawa Y; Deguchi T; Ito M Cytokine; 2013 Oct; 64(1):251-7. PubMed ID: 23876400 [TBL] [Abstract][Full Text] [Related]
6. Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer. Hao J; Ci X; Xue H; Wu R; Dong X; Choi SYC; He H; Wang Y; Zhang F; Qu S; Zhang F; Haegert AM; Gout PW; Zoubeidi A; Collins C; Gleave ME; Lin D; Wang Y Eur Urol; 2018 Jun; 73(6):949-960. PubMed ID: 29544736 [TBL] [Abstract][Full Text] [Related]
7. Analysis of cabazitaxel-resistant mechanism in human castration-resistant prostate cancer. Hongo H; Kosaka T; Oya M Cancer Sci; 2018 Sep; 109(9):2937-2945. PubMed ID: 29989268 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of Pten deficient Castration Resistant Prostate Cancer by Targeting of the SET - PP2A Signaling axis. Hu X; Garcia C; Fazli L; Gleave M; Vitek MP; Jansen M; Christensen D; Mulholland DJ Sci Rep; 2015 Nov; 5():15182. PubMed ID: 26563471 [TBL] [Abstract][Full Text] [Related]
9. MiR-4638-5p inhibits castration resistance of prostate cancer through repressing Kidins220 expression and PI3K/AKT pathway activity. Wang Y; Shao N; Mao X; Zhu M; Fan W; Shen Z; Xiao R; Wang C; Bao W; Xu X; Yang C; Dong J; Yu D; Wu Y; Zhu C; Wen L; Lu X; Lu YJ; Feng N Oncotarget; 2016 Jul; 7(30):47444-47464. PubMed ID: 27329728 [TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase 1 promotes glioblastoma cell proliferation and invasion via activation of PI3K/AKT and MEK/ERK signaling pathways. Li S; Chen X; Mao L; Zahid KR; Wen J; Zhang L; Zhang M; Duan J; Duan J; Yin X; Wang Y; Zhao L; Tang X; Wang X; Xu G Brain Res; 2018 Aug; 1692():154-162. PubMed ID: 29782850 [TBL] [Abstract][Full Text] [Related]
11. S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer. Zhu W; Xue Y; Liang C; Zhang R; Zhang Z; Li H; Su D; Liang X; Zhang Y; Huang Q; Liu M; Li L; Li D; Zhao AZ; Liu Y Tumour Biol; 2016 Sep; 37(9):12241-12250. PubMed ID: 27240591 [TBL] [Abstract][Full Text] [Related]
12. Sophocarpine inhibits tumor progression by antagonizing the PI3K/AKT/mTOR signaling pathway in castration-resistant prostate cancer. Weng M; Shi C; Han H; Zhu H; Xiao Y; Guo H; Yu Z; Wu C PeerJ; 2022; 10():e14042. PubMed ID: 36132221 [TBL] [Abstract][Full Text] [Related]
13. Autocrine Activation of CHRM3 Promotes Prostate Cancer Growth and Castration Resistance via CaM/CaMKK-Mediated Phosphorylation of Akt. Wang N; Yao M; Xu J; Quan Y; Zhang K; Yang R; Gao WQ Clin Cancer Res; 2015 Oct; 21(20):4676-85. PubMed ID: 26071486 [TBL] [Abstract][Full Text] [Related]
14. SPP1 Promotes Enzalutamide Resistance and Epithelial-Mesenchymal-Transition Activation in Castration-Resistant Prostate Cancer via PI3K/AKT and ERK1/2 Pathways. Pang X; Zhang J; He X; Gu Y; Qian BZ; Xie R; Yu W; Zhang X; Li T; Shi X; Zhou Y; Cui Y Oxid Med Cell Longev; 2021; 2021():5806602. PubMed ID: 34721759 [TBL] [Abstract][Full Text] [Related]
15. Corosolic acid, a natural triterpenoid, induces ER stress-dependent apoptosis in human castration resistant prostate cancer cells via activation of IRE-1/JNK, PERK/CHOP and TRIB3. Ma B; Zhang H; Wang Y; Zhao A; Zhu Z; Bao X; Sun Y; Li L; Zhang Q J Exp Clin Cancer Res; 2018 Sep; 37(1):210. PubMed ID: 30176898 [TBL] [Abstract][Full Text] [Related]
16. MYSM1-AR complex-mediated repression of Akt/c-Raf/GSK-3β signaling impedes castration-resistant prostate cancer growth. Sun J; Hu X; Gao Y; Tang Q; Zhao Z; Xi W; Yang F; Zhang W; Song Y; Song B; Wang T; Wang H Aging (Albany NY); 2019 Nov; 11(22):10644-10663. PubMed ID: 31761786 [TBL] [Abstract][Full Text] [Related]
17. LncRNA PCAT1 activates AKT and NF-κB signaling in castration-resistant prostate cancer by regulating the PHLPP/FKBP51/IKKα complex. Shang Z; Yu J; Sun L; Tian J; Zhu S; Zhang B; Dong Q; Jiang N; Flores-Morales A; Chang C; Niu Y Nucleic Acids Res; 2019 May; 47(8):4211-4225. PubMed ID: 30773595 [TBL] [Abstract][Full Text] [Related]
19. Snail promotes cell migration through PI3K/AKT-dependent Rac1 activation as well as PI3K/AKT-independent pathways during prostate cancer progression. Henderson V; Smith B; Burton LJ; Randle D; Morris M; Odero-Marah VA Cell Adh Migr; 2015; 9(4):255-64. PubMed ID: 26207671 [TBL] [Abstract][Full Text] [Related]
20. Integrated network model provides new insights into castration-resistant prostate cancer. Hu Y; Gu Y; Wang H; Huang Y; Zou YM Sci Rep; 2015 Nov; 5():17280. PubMed ID: 26603105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]